Accenture and Roche are teaming up on a new collaboration aimed at improving how oncology teams prepare for, conduct and document clinical treatment decisions for cancer patients in hospitals. Under the terms of the multi-year agreement, Accenture will provide digital health data integration services to Roche’s NAVIFY Tumor Board solution – fostering more efficient collaboration, reducing errors and giving care teams more time to evaluate individual patient cases.
What Is A Tumor Board?
A tumor board is a meeting in which multi-disciplinary healthcare teams review and discuss individual cancer patient cases and available treatment options. The NAVIFY Tumor Board solution streamlines and standardizes the tumor board workflow process by aggregating relevant patient data from disparate IT systems into a software solution that fosters efficient team collaboration, reduces errors, and gives the care team more time to evaluate individual patient cases.
Accenture’s capabilities will allow Roche to collect and replicate sensitive patient data between hospitals and the NAVIFY Tumor Board solution to help clinicians make the best possible treatment decisions for their patients.
“Our collaboration with Accenture is another exciting step forward in providing personalized healthcare solutions to patients,” said Tim M. Jaeger, Global Head of Diagnostics Information Solutions for Roche in a statement. “Tumor board coordination is labor intensive and time consuming for healthcare providers. Accenture’s global scale, deep digital expertise, and innovation capabilities in the healthcare and life sciences industries allows Roche to continue our focus on delivering workflow and decision support solutions to customers and improving patient outcomes.”
This is not the first time that Roche and Accenture have joined forces. In July 2017, they announced a five-year collaboration to improve diabetes care management and delivery using data analytics.
